Windsor Private Capital Lp Sells 32,136 Shares of Firefly Neuroscience (NASDAQ:AIFF) Stock

Firefly Neuroscience, Inc. (NASDAQ:AIFF) major shareholder Windsor Private Capital Lp sold 32,136 shares of the stock in a transaction dated Monday, October 13th. The shares were sold at an average price of $2.65, for a total transaction of $85,160.40. Following the completion of the sale, the insider directly owned 1,499,701 shares in the company, valued at approximately $3,974,207.65. The trade was a 2.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Windsor Private Capital Lp also recently made the following trade(s):

• On Tuesday, October 14th, Windsor Private Capital Lp sold 29,500 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.74, for a total transaction of $80,830.00.
• On Friday, October 10th, Windsor Private Capital Lp sold 74,810 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.70, for a total transaction of $201,987.00.
• On Thursday, October 9th, Windsor Private Capital Lp sold 30,126 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.94, for a total transaction of $88,570.44.

Firefly Neuroscience Trading Down 0.4%

Shares of NASDAQ AIFF opened at $2.74 on Thursday. Firefly Neuroscience, Inc. has a 52 week low of $1.86 and a 52 week high of $17.20. The stock has a market cap of $36.85 million, a price-to-earnings ratio of -1.10 and a beta of 2.11. The company’s 50-day moving average price is $2.79 and its 200 day moving average price is $3.00.

Firefly Neuroscience (NASDAQ:AIFF) last released its quarterly earnings results on Wednesday, August 13th. The company reported ($0.14) earnings per share (EPS) for the quarter. Firefly Neuroscience had a negative return on equity of 464.02% and a negative net margin of 5,335.75%.

Institutional Investors Weigh In On Firefly Neuroscience

An institutional investor recently raised its position in Firefly Neuroscience stock. Geode Capital Management LLC increased its stake in Firefly Neuroscience, Inc. (NASDAQ:AIFF) by 92.9% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 120,604 shares of the company’s stock after acquiring an additional 58,067 shares during the period. Geode Capital Management LLC owned approximately 0.94% of Firefly Neuroscience worth $341,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 4.96% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Firefly Neuroscience in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has an average rating of “Sell”.

Firefly Neuroscience Company Profile

Firefly Neuroscience, Inc, a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.